Fort Worth, TX, United States of America

G Michael Wall

This inventor holds 17 USPTO granted patents and 26 published patent applications, plus 6 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Treatments. Top assignees: Nacuity Pharmaceuticals, Inc., Alcon Pharmaceuticals Ltd., Novartis Ag. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: G Michael Wall. Retrieved from https://idiyas.com/inventor/g-michael-wall

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 17 (Patent Applications = 26)

% Patents Active = 64.7

CIPO Patents = 6 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 12)

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 53(Granted Patents)

Company Filing History:

10 out of 13

Nacuity Pharmaceuticals, Inc.

patents

4 out of 28

Alcon Pharmaceuticals Ltd.

Nacuity Pharmaceutials, Inc.

patent

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

N-Acetylcysteine Amide

Radiation Dermatitis

Middle Ear Infections

Oxidative Stress

Age-Related Macular Degeneration

Glaucoma

Cystic Fibrosis

Skin Lightening

Deuterium-Enriched Compounds

Pulmonary Function

Usher Syndrome

Diabetic Retinopathy

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12780781 - Methods of making deuterium-enriched n-acetylcysteine amide (d-NACA) and (2R,2R)-3,3-disulfanediyl BIS(2-acetamidopropanamide) (diNACA) and using d-NACA and diNACA to treat diseases involving oxidative stress (2026-11-03),

2. 12778913 - Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylcysteine amide (NACA) or (2R,2R')-3,3′-disulfanediyl BIS(2-acetamidopropanamide)(DiNACA) (2026-11-03),

3. 12667548 - Treatment of retinitis pigmentosa and retinitis pigmentosa associated with Usher Syndrome with N-acetylcysteine amide (2026-06-30),

4. 12662449 - Method for preparation of N-acetyl cysteine amide and derivatives thereof (2026-06-23),

5. 12458608 - N-Acetylcysteine Amide (NACA) and (2R,2R')-3,3′ disulfanediyl BIS(2-acetamidopropanamide) (DINACA) for the prevention and treatment of radiation dermatitis and skin lightening, skin whitening and skin improvement (2025-11-04),

6. 12245998 - N-acetylcysteine amide (NACA) and (2R,2R')-3,3′ disulfanediyl bis(2-acetamidopropanamide) (diNACA) for the prevention and treatment of radiation pneumonitis and treatment of pulmonary function in Cystic Fibrosis (2025-03-11),

7. 11766413 - Treatment of age-related macular degeneration, glaucoma, and diabetic retinopathy with n-acetylcysteine amide (NACA) or (2R,2R')-3,3′-disulfanediyl BIS(2-acetamidopropanamide)(DiNACA) (2023-09-26),

8. 11753370 - Methods of making deuterium-enriched N-acetylcysteine amide (d-NACA) and (2R, 2R')-3,3′-disulfanediyl bis(2-acetamidopropanamide) (diNACA) and using d-NACA and diNACA to treat diseases involving oxidative stress (2023-09-12),

9. 11548851 - Method for preparation of n-acetyl cysteine amide and derivatives thereof (2023-01-10),

10. 11091433 - Method for preparation of N-acetyl cysteine amide and derivatives thereof (2021-08-17),

11. 10590073 - Method for preparation of N-acetyl cysteine amide and derivatives thereof (2020-03-17),

12. 9402805 - Method of treating middle ear infections (2016-08-02),

13. 9345714 - Method of treating middle ear infections (2016-05-24),

14. 9149486 - Method of treating middle ear infections (2015-10-06),

15. 8846650 - Method of treating middle ear infections (2014-09-30),

Title: The Innovative Journey of G Michael Wall

Introduction: G Michael Wall, a distinguished inventor hailing from Fort Worth, TX, has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: G Michael Wall's latest patents include cutting-edge solutions in the fields of renewable energy, artificial intelligence, and sustainable agriculture.

Career Highlights: With a career spanning over two decades, G Michael Wall has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing inventive solutions to address them. His work has not only revolutionized industries but has also improved the lives of many around the globe.

Collaborations: Throughout his career, G Michael Wall has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, G Michael Wall's passion for innovation, coupled with his relentless drive to push the boundaries of what is possible, has solidified his position as a trailblazing inventor in the world of technology. His contributions continue to inspire future generations of inventors to think boldly and create fearlessly.

Profile summary based on public USPTO records.